Wegovy Price 2026: What to Expect and How to Afford It

If you're researching Wegovy in 2026, you've likely already discovered it's one of the most effective FDA-approved medications for weight loss—and one of the most expensive. The sticker shock is real, and you're not alone in wondering whether you can actually afford it. The good news? There are several ways to access GLP-1 medications for weight loss without breaking the bank, and understanding the full pricing landscape helps you make the best decision for your health and budget.

Let's walk through exactly what Wegovy costs in 2026, what insurance typically covers, and what realistic alternatives exist.

What Is Wegovy?

Wegovy is the brand name for semaglutide when prescribed specifically for weight management. It's manufactured by Novo Nordisk and FDA-approved for adults with obesity (BMI of 30+) or overweight (BMI of 27+) with at least one weight-related condition like high blood pressure or type 2 diabetes.

The medication works by mimicking GLP-1, a hormone that regulates appetite and blood sugar. Clinical trials showed patients lost an average of 15-20% of their body weight over 68 weeks, making it one of the most effective pharmaceutical weight loss options available.

Wegovy List Price in 2026

As of 2026, the list price for Wegovy remains approximately $1,349 to $1,450 per month without insurance or discount programs. This translates to roughly $16,000 to $17,400 annually.

The price hasn't changed dramatically from 2025, though Novo Nordisk has faced continued pressure from advocacy groups and legislators to reduce costs. Despite ongoing negotiations, the manufacturer has maintained pricing largely due to high demand and limited production capacity.

Why Is Wegovy So Expensive?

Several factors contribute to Wegovy's high cost. Development costs for GLP-1 medications were substantial, involving years of clinical trials. Manufacturing these peptide-based medications requires sophisticated facilities and quality control. Perhaps most significantly, demand has consistently outpaced supply since launch, allowing the manufacturer to maintain premium pricing.

Patent protection also means no generic versions are expected until the early 2030s.

Does Insurance Cover Wegovy in 2026?

Insurance coverage for Wegovy varies widely and remains the biggest factor in what you'll actually pay.

Commercial Insurance

Approximately 40-50% of commercial insurance plans now cover Wegovy in 2026, up from roughly 30% in 2024. However, coverage often comes with significant requirements including prior authorization, documented diet and exercise attempts, and BMI thresholds.

Even with coverage, you may face copays ranging from $25 to $500 monthly depending on your plan's tier structure.

Medicare

Traditional Medicare still does not cover weight loss medications as of 2026, though some Medicare Advantage plans have begun offering limited coverage. This remains a significant barrier for adults over 65.

Medicaid

Medicaid coverage varies by state. As of 2026, approximately 15 states provide coverage for Wegovy under specific circumstances, primarily when prescribed for obesity-related health conditions.

Wegovy Savings Programs and Discounts

Novo Nordisk Savings Card

The manufacturer offers a savings card that can reduce costs to as little as $0-25 per month for up to 13 fills if you have commercial insurance. This program specifically excludes government insurance like Medicare and Medicaid.

The savings card has income and eligibility restrictions, and program terms can change. Check the official Novo Nordisk website or ask your pharmacy for current details.

Patient Assistance Programs

For uninsured or underinsured patients meeting income requirements (typically below 400% of federal poverty level), Novo Nordisk's patient assistance program may provide Wegovy at no cost. The application process requires documentation from your physician and proof of financial need.

Affordable Alternatives to Brand-Name Wegovy

If Wegovy's price remains out of reach even with assistance programs, several alternatives deserve consideration.

Compounded Semaglutide

Compounded semaglutide contains the same active ingredient as Wegovy but is prepared by specialized pharmacies rather than the brand manufacturer. This option typically costs $200-400 monthly through most providers, making it significantly more affordable.

Compounded medications are legal and regulated by state pharmacy boards, though they don't go through the same FDA approval process as brand medications. They're particularly accessible during drug shortage periods.

Other GLP-1 Medications

Tirzepatide (brand name Zepbound for weight loss) offers similar or even superior weight loss results in clinical trials. Pricing is comparable to Wegovy at around $1,200+ monthly, but some patients find better insurance coverage or savings program options.

Compounded tirzepatide is also available at similar price points to compounded semaglutide.

Gender Considerations for Wegovy

Clinical trials showed Wegovy effective for both women and men, though some gender differences are worth noting. Women in trials reported slightly higher rates of nausea and gastrointestinal side effects, particularly during dose escalation.

Women of childbearing age should discuss pregnancy planning with their physician, as Wegovy should be discontinued at least two months before attempting to conceive.

Men in trials showed comparable weight loss percentages to women, though the absolute weight lost was often higher due to typically higher starting weights.

Making Wegovy Affordable: Your Action Plan

Start by checking your insurance formulary to see if Wegovy is covered and what your specific copay would be. Contact your insurance directly rather than relying on general information, as coverage varies significantly between plans.

If you have commercial insurance and coverage, apply for the Novo Nordisk savings card before your first fill. If you're uninsured or have government insurance, explore the patient assistance program early, as applications can take several weeks.

Consider whether compounded semaglutide or tirzepatide might meet your needs at a more manageable price point. Many patients achieve excellent results with these alternatives at a fraction of the brand-name cost.

From the Ozari Care Team

The most important factor in GLP-1 therapy success isn't whether you use brand-name or compounded medication—it's consistent access and proper medical supervision. We see many patients achieve remarkable results with compounded semaglutide who might have discontinued brand-name options due to cost. The best medication is the one you can afford to take consistently while working with a physician who monitors your progress and adjusts your protocol as needed.

Start Your Weight Loss Journey Today

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 28, 2026